Grégoire Martin de Frémont
@gregoiremdf.bsky.social
MD @APHP - PhD student @KarolinskaInstitutet
Reposted by Grégoire Martin de Frémont
Also great to see further reassuring data for anakinra in pregnancy, now out from France academic.oup.com/rheumatology...
Exposure during pregnancy to Il-1 targeted therapies and pregnancy, fetal and neonatal outcomes: a study from the French Teratology Information Service
AbstractOBJECTIVE. To describe the outcomes of pregnancies exposed to IL-1 targeted therapies (anti-IL-1): anakinra and/or canakinumab.METHODS. We performe
academic.oup.com
July 14, 2025 at 7:06 AM
Also great to see further reassuring data for anakinra in pregnancy, now out from France academic.oup.com/rheumatology...
Reposted by Grégoire Martin de Frémont
Inflammatory response to UVB exposure in Trim21-/- mice
doi.org/10.1002/art....
Open-label trial of escalation to golimumab in early axSpA gut inflammation
doi.org/10.1002/art....
doi.org/10.1002/art....
Open-label trial of escalation to golimumab in early axSpA gut inflammation
doi.org/10.1002/art....
Loss of TRIM21 drives UVB‐induced systemic inflammation by regulating DNA‐sensing pathways
Background Patients with systemic lupus erythematosus (SLE) experience photosensitivity, with exposure to ultraviolet light B (UVB) driving lupus flares and triggering symptoms like joint pain, fati...
doi.org
June 21, 2025 at 2:07 PM
Inflammatory response to UVB exposure in Trim21-/- mice
doi.org/10.1002/art....
Open-label trial of escalation to golimumab in early axSpA gut inflammation
doi.org/10.1002/art....
doi.org/10.1002/art....
Open-label trial of escalation to golimumab in early axSpA gut inflammation
doi.org/10.1002/art....